Dima Martini
Company: Astellas Pharma
Job title: Lead- Global Early-Stage Medical Affairs, Mitochondrial and Rare Disease
Seminars:
Panel Discussion: Translating Modality Into Value for Patients to Establish Clearly Defined Clinical Objectives 1:30 pm
Building on the industry’s failures to re-evaluate how to select and measure the right clinical outcome Steering the direction of research to acquire robust data that can illustrate clinical translatability and expedite discovery towards Phase I of clinical trials Positioning patients at the heart of the modality to demonstrate its viability, thereby eliminating the need…Read more
day: CONFERENCE DAY ONE
Evaluating Decision-Making Behind Therapeutic Development 4:00 pm
Analyzing the immensity of cost, time and investment required for mitochondrial drug development Demonstrating the long-term value of mitochondrial therapeutics to regulators early on for expanded therapeutic opportunities Creating incentives for mitochondrial disease programs to build a promising strategy for regulatory recognitionRead more
day: Pre-Conference Workshop Day